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Aim: To investigate the protective effects of arctigenin (ATG), a phenylpropanoid dibenzylbutyrolactone lignan from Arctium lappa L 
(Compositae), against ER stress in vitro and the underlying mechanisms.
Methods: A cell-based screening assay for ER stress regulators was established.  Cell viability was measured using MTT assay.  PCR 
and Western blotting were used to analyze gene and protein expression.  Silencing of the CaMKKβ, LKB1, and AMPKα1 genes was 
achieved by RNA interference (RNAi).  An ATP bioluminescent assay kit was employed to measure the intracellular ATP levels.  
Results: ATG (2.5, 5, and 10 µmol/L) inhibited cell death and unfolded protein response (UPR) in a concentration-dependent manner in 
cells treated with the ER stress inducer brefeldin A (100 nmol/L).  ATG (1, 5, and 10 µmol/L) significantly attenuated protein synthesis 
in cells through inhibiting mTOR-p70S6K signaling and eEF2 activity, which were partially reversed by silencing AMPKα1 with RNAi. ATG 
(1–50 µmol/L) reduced intracellular ATP level and activated AMPK through inhibiting complex I-mediated respiration.  Pretreatment of 
cells with the AMPK inhibitor compound C (25 µmol/L) rescued the inhibitory effects of ATG on ER stress.  Furthermore, ATG (2.5 and 5 
µmol/L) efficiently activated AMPK and reduced the ER stress and cell death induced by palmitate (2 mmol/L) in INS-1 β cells.
Conclusion: ATG is an effective ER stress alleviator, which protects cells against ER stress through activating AMPK, thus attenuating 
protein translation and reducing ER load. 
Keywords: arctigenin; ER stress; human hepatocellular liver carcinoma cell; β-cell death; mTOR-p70S6K; eukaryotic translation elonga-
tion factor 2 (eEF2); mitochondrial respiration; AMPK
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Introduction
The endoplasmic reticulum (ER) is a highly dynamic organelle 
in which proteins and lipids are synthesized, modified, and 
transported.  Under conditions such as glucose starvation, 
hypoxia, aberrant Ca
2+ regulation, and virus infection, collec-
tively known as ER stress, proteins fail to be correctly folded 
and eventually accumulate and aggregate in the ER lumen.  In 
response to the abnormalities in the ER, the ER stress response 
or the unfolded protein response (UPR) is triggered by three 
ER-localized transmembrane proteins: PKR-like ER kinase 
(PERK), activation transcription factor (ATF6), and inositol-
requiring kinase (IRE1).  During the ER stress response, PERK 
phosphorylates and inhibits eukaryotic initiation factor 2α 
(eIF2α), leading to translation attenuation
[1]; ATF6 translo-
cates to the Golgi, where it is sequentially cleaved by the S1P 
and S2P proteases to form an active 50 kDa transcription fac-
tor
[2]; and IRE1 cleaves the mRNA transcript of X box protein 
1 (XBP1) by an unconventional splicing mechanism
[3].  The 
activation of these pathways restricts protein load on the ER 
through transient attenuation of general protein synthesis, 
promotes degradation of misfolded proteins and increases 
protein folding capacity in the ER
[4].  However, severe or pro-
longed accumulation of unfolded proteins triggers apoptosis 
of target cells.  
Accumulating evidence suggest that ER stress is implicated 
in a wide range of diseases, including diabetes, neurodegen-
eration, stroke, cardiac disease, muscle degeneration and 
others
[5].  Particularly, ER stress has been reported to play a 
central role in pancreatic β-cell demise in type 2 diabetes and 
perhaps also in type 1 diabetes
[6].  Elevated ER stress markers 
have been detected in islet tissues of diet-induced and genetic 
db/db diabetic mice
[7], as well as of type 2 diabetes patients
[8].   
Thus, we hypothesize that alleviation of ER stress may rep-
resent an attractive therapeutic strategy for the treatment of 
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β-cell death in type 2 diabetes.  
Arctigenin (ATG) is a phenylpropanoid dibenzylbutyro-
lactone lignan from Arctium lappa L (Compositae)
[9].  Arctium 
lappa L, commonly known as burdock, has been widely used 
in traditional Chinese medicine (TCM) for treating inflamma-
tion
[10].  It has also been used therapeutically in Europe and 
North America for hundreds of years
[11].  The root of Arctium 
lappa L, a popular edible vegetable in China and Japan, is used 
to make a general health tonic.  Previous studies have shown 
that ATG exerted protective effects against oxidation
[12], viral 
infection
[13], and cancer
[14].  Most recently, two research groups 
have reported that ATG could block the UPR and preferen-
tially inhibit tumor cell viability under glucose-deprived con-
ditions
[15, 16].  The molecular targets and mechanisms of ATG 
however remain unclear.  
In the present study, we established a cell-based screening 
assay for ER stress regulators and identified ATG as a protec-
tive agent against ER stress, which efficiently protected HepG2 
cells from the ER stress inducer brefeldin A (BFA)-induced 
cell death, and investigated its action mechanism.  We then 
explored its therapeutic potential in treating diabetes by exam-
ining its effects on palmitate-induced β-cell death. 
Materials and methods
Reagents and antibodies
Arctigenin (purity >99%), isolated from dried seeds of A.  lappa 
as previously described
[17], was provided by Dr Li-hong HU.   
Penicillin, streptomycin, Brefeldin A, compound C, 5-amin-
oimidazole-4-carboxamide ribonucleoside (AICAR), D-glu-
cose, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) and propidium iodide (PI) were purchased 
from Sigma (St Louis, Mo, USA).  Palmitate was purchased 
from Takeda Chemical Industries (TCI, Tokyo, Japan).  Fatty 
acid-free bovine serum albumin (BSA) was purchased from 
Equitech-Bio (Kerrville, TX, USA).  α-MEM medium, RPMI-
1640 medium and fetal bovine serum (FBS) were purchased 
from Invitrogen (Carlsbad, CA, USA).  All other chemicals 
(molecular biology grade) were obtained from standard com-
mercial sources.  Anti-PARP antibody, anti-phosphorylated 
AMPKα (Thr172), anti-phosphorylated acetyl-CoA carboxy-
lase (ACC, Ser79), anti-phosphorylated eIF2α (Ser51), anti-
eIF2α, anti-phosphorylated mTOR (Ser2448), anti-mTOR, anti-
phosphorylated p70S6K (Thr389), anti-p70S6K, anti-phospho-
rylated eEF2 (Thr56), anti-eEF2, and anti-GAPDH antibodies 
were purchased from Cell Signaling Technology (Beverly, MA, 
USA).  Anti-AMPKα antibody was purchased from Epitomics 
(Burlingame, CA, USA).  
Cell culture
HepG2 cells, a human hepatocellular liver carcinoma cell 
line, were grown in α-MEM containing 10% (v/v) FBS, 100 
U/mL penicillin and 100 μg/mL streptomycin.  INS-1 β-cells, 
a rat insulinoma cell line, were grown in RPMI-1640 medium 
supplemented with 10% FBS, 1 mmol/L sodium pyruvate, 
2 mmol/L L-glutamine, 10 mmol/L HEPES, 0.05 mmol/L 
2-mercaptoethanol, 100 units/mL penicillin and 100 mg/mL 
streptomycin.  All cell lines were cultured at 37 °C in a humidi-
fied atmosphere of 95% air and 5% CO2.
MTT assay and PI staining
Cell growth rate was measured by the MTT assay.  Briefly, 
after treatment, 20 μL MTT (5 mg/mL) was added to the cul-
ture medium.  After incubating for 3 h at 37 °C, the cells were 
solubilized in dimethyl sulfoxide (DMSO), and the absorbance 
of each well was measured at 570 nm with a spectrophotom-
eter (Molecular Devices, Silicon Valley, CA, USA).  Cell death 
was examined by PI staining.  After treatment, cells were 
stained with 15 μg/mL PI for 10 min, and then washed with 
PBS and photographed using a UV microscope.  
Western blot analysis
Cells were lysed with 1×Laemmli buffer (Sigma, St Louis, 
MO, USA) containing 2 mmol/L NaF and 2 mmol/L Na3VO4, 
which are used to prevent the dephosphorylation of serine/
threonine and tyrosine residues, respectively.  Proteins were 
separated by sodium dodecyl sulphate (SDS) polyacrylamide 
gel electrophoresis and transferred to a nitrocellulose mem-
brane (Millipore, Bedford, MA, USA).  Membrane was blocked 
in 5% nonfat milk for 1 h at room temperature and then sub-
jected to immunostaining with primary antibodies at 4 °C 
overnight and peroxidase-conjugated secondary antibodies 
at room temperature for 1 h.  Immunoreactivity was revealed 
with the Supersignal chemiluminescence dection kit (Pierce, 
Rockford, IL, USA).  Immunoblots were scanned and quanti-
fied using the software ImageJ (NIH).  
Isolation of total RNA, semiquantitative and quantitative reverse 
transcription PCR
Total RNA was extracted from cells using TRIzol reagent 
(Invitrogen, Paisley, UK) following the manufacturer’s instruc-
tions.  4 μg total RNA and ReverTra Ace reverse transcriptase 
(Toyobo, Osaka, Japan) were used in the reverse transcription 
reaction.  
Taq DNA polymerase (Takara, Tokyo, Japan) was used 
for the subsequent polymerase chain reaction (PCR).  The 
specific primers for semiquantitative PCR were as follows: 
5’-CCTTGTAGTTGAGAACCA-3’ (forward) and 5’-GGGCT-
TGGTATATATGTGGG-3’ (reverse) for both unspliced 
and spliced XBP-1 (human); 5’-ACCACAGTCCATGCCA-
TCAC-3’ (forward) and 5’-TCCACCACCCTGTTGCTG-3’ 
(reverse) for GAPDH (human); 5’-TTACGAGAGAAAACT-
CATGGGC-3’ (forward) and 5’-GGGTCCAACTTGTCCA-
GAATGC-3’ (reverse) for both unspliced and spliced XBP-1 
(rat); 5’-CCCCAATGTATCCGTTGTGGA-3’ (forward) and 
5’-GCCTGCTTCACCACCTTCTT-3’ (reverse) for GAPDH 
(rat).  RT–PCR for XBP-1 was performed for 30 cycles and 
GAPDH for 20 cycles.  PCR products were separated on 8% 
polyacrylamide gel and visualized by ethidium bromide stain-
ing.
Quantitative PCR was performed and analyzed in ABI-
PRISM 7700 Sequence Detection System (Applied Bio-
systems) with SYBR green real-time PCR kit (Takara).   943
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The specific primer sequences were as follows: 5’-GGC-
CAGTTTGGTGTCGGTTT-3’ (forward) and 5’-CGTTC-
CCCGTCCTAGAGTGTT-3’ (reverse) for Grp94 (human); 
5’-TGGACTGCAGGTGCTGATAG-3’ (forward) and 
5’-GGATTCTTGGTTGCCTGGTA-3’ (reverse) for EDEM 
(human); 5’-TCAAACCTCATGGGTTCTCC-3’ (forward) 
and 5’-GTGTCATCCAACGTGGTCAG-3’ (reverse) for ATF4 
(human); 5’-TGTGACCTCTGCTGGTTCTG-3’ (forward) and 
5’-TGGAAGCCTGGTATGAGGAC-3’ (reverse) for CHOP 
(human); 5’- CACGTCCAACCCGGAGAA-3’ (forward) and 
5’-ATTCCAAGTGCGTCCGATG-3’ (reverse) for Grp78 (Rat); 
5’-TACTATGCCAGTCAGAAGAAAACG-3’ (forward) and 
5’-CATCCTTTCTATCCTGTCTCCATA-3’ (reverse) for Grp94 
(Rat); 5’-GACATGCCGCCTGGAGAAAC-3’ (forward) and 
5’-AGCCCAGGATGCCCTTTAGT-3’ (reverse) for GAPDH 
(Rat).
RNA interference and transfection
Small interfering RNAs (siRNAs) against Ca
2+/calmodulin-
dependent protein kinase kinase β (CaMKKβ), liver kinase 
B1 (LKB1) and AMPKα1 as well as a nonsilencing con-
trol siRNA were purchased from GenePhama (Shanghai, 
China).  The siRNA sequences applied to target CaMKKβ 
were: 5’-CGAUCGUCAUCUCUGGUUAdTdT-3’ (sense) and 
5’-UAACCAGAGAUGACGAUCGdTdT-3’ (antisense); for 
LKB1, 5’-GGCUCUUACGGCAAGGUGAdTdT-3’ (sense) and 
5’-UCACCUUGCCGUAAGAGCCdTdT-3’ (antisense) and, for 
AMPKα1, 5’-UGCCUACCAUCUCAUAAUAdTdT-3’ (sense) 
and 5’-UAUUAUGAGAUGGUAGGCAdTdT-3’ (antisense) 
were used.  The siRNA sequences employed as a negative con-
trol were 5’-UUCUCCGAACGUGUCACGUTT-3’ (sense) and 
5’-ACGUGACACGUUCGGAGAATT-3’ (antisense).
Transfections of HepG2 cells with siRNA or a plasmid 
encoding green fluorescent protein were performed using 
Lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s protocol.
Determination of intracellular ATP content
The luciferin-luciferase assay was used to measure intracellu-
lar ATP levels.  Briefly, after rinsing three times with PBS, cells 
were solubilized in 200 μL (for 24-well plate) of somatic cell 
ATP-releasing agent (Sigma, St Louis, MO, USA).  Samples 
were centrifuged for 5 min in a microcentrifuge.  Determina-
tion of ATP levels was accomplished by combining equal vol-
umes of supernatant with an ATP assay mix (Sigma, St Louis, 
MO, USA) and measuring the level of chemiluminescence.   
Measurements are expressed as a percent of the initial value 
after subtraction of background countings.  
Mitochondrial respiration measurements
Mitochondria were isolated from the muscles of male Wistar 
rats following standard procedures
[18].  To measure respira-
tion rate, mitochondria were incubated at 37 °C in a Clark 
type oxygen electrode (Strathkelvin Instruments, Motherwell, 
Scotland) in a buffer (pH 7.0) composed of 225 mmol/L man-
nitol, 75 mmol/L sucrose, 10 mmol/L Tris-HCl, 10 mmol/L 
KH2PO4, 10 mmol/L KCl, 0.8 mmol/L MgCl2, 0.1 mmol/L 
EDTA, 0.3% fatty acid free BSA.  The respiratory control ratio, 
the ratio of state III to state IV respiration, was approximately 
5, indicating that the isolated mitochondria were well coupled.   
Effects of ATG on mitochondrial respiration were determined 
in the presence of excess ADP (2.4 mmol/L), using substrate 
combinations targeting either complex I (5 mmol/L pyruvate 
plus 2 mmol/L malate) or complex II (10 mmol/L succinate 
plus 4 μmol/L rotenone) of the respiratory chain.  
Palmitate-BSA solution preparation
Palmitate was dissolved in ethanol: H2O (1: 1, v/v) at 50 °C at a 
concentration of 400 mmol/L.  The palmitate solution 150 μL 
was then mixed with 3 mL fatty acid-free BSA (20% solution in 
H2O) by stirring at 37 °C for 1 h.  The final molar ratio of palm-
itate to BSA was 6.7: 1 and the final concentration of palmitate-
BSA is 20 mmol/L.  All control conditions included a solution 
of vehicle (ethanol: H2O) mixed with fatty acid-free BSA at the 
same concentration as the palmitate-BSA solution.
Statistical analysis
Triplicates were used in each experiment and data were 
shown only if three independent experiments showed consis-
tent results.  All results are expressed as the mean±SEM.  Sta-
tistical differences between groups were determined by using 
the unpaired Student’s t-test.  P<0.05 was considered statisti-
cally significant.  P<0.05, P<0.01 vs control.
Results
ATG protects HepG2 cells from BFA-induced apoptosis
We identified ATG as a protective agent against ER stress 
through a cell-based assay, in which ER stress was induced by 
treating HepG2 cells with BFA, an ER-to-Golgi vesicle trans-
port inhibitor.  The MTT assay demonstrated that only 27% 
of the cells had survived at 72 h after BFA treatment.  How-
ever, ATG inhibited the BFA-induced cell death in a dose-
dependent manner (Figure 1A).  Meanwhile, a higher concen-
tration of ATG (> 10 µmol/L) on its own caused a statistically 
significant decrease in cell number (Figure 1A), so we chose 5 
μmol/L for further studies of its effects on reducing ER stress.
To determine whether ATG specifically affects the ER stress-
induced cell death, we investigated the effects of ATG on cell 
death induced by non-ER stress stimuli, including protein syn-
thesis inhibitor cycloheximide (CHX), DNA topoisomerase II 
inhibitor adriamycin (ADM), and the mitochondrial complex 
I inhibitor berberine (BBR)
[18].  Our data showed that ATG had 
no protective effect against CHX-, ADM-, or BBR-induced cell 
death, which indicates that ATG may specifically inhibit ER 
stress-induced cell death (Figure 1B).
The protective effect of ATG against BFA-induced cell death 
was further confirmed by PI (propidium iodide) staining and 
PARP cleavage assay.  As shown in Figure 1C, BFA increased 
the number of round and PI-stained cells, which were obvi-
ously inhibited by ATG.  As reported, BFA induced apoptosis 
as indicated by poly (ADP-ribose) polymerase (PARP) cleav-
age.  Co-treatment with ATG significantly prevented the BFA-944
www.nature.com/aps
Gu Y et al
Acta Pharmacologica Sinica
npg
induced PARP cleavage (Figure 1D).  Meanwhile, ATG per 
se did not increase the number of PI-stained cells or induce 
PARP cleavage (Figure 1C and 1D).  These data demonstrate 
that ATG can effectively protect HepG2 cells from the ER 
stress inducer (BFA)-induced apoptosis.
ATG down-regulates UPR signaling pathways induced by ER 
stress
To confirm that ATG protects cells from apoptosis by allevi-
ating ER stress, we investigated the effects of ATG on UPR 
signaling pathways.  Our data showed that BFA increased the 
Figure 1.  ATG specifically inhibits BFA-induced apoptosis.  (A) HepG2 cells were cultured for 72 h with increasing concentrations of ATG alone, or in 
combination with 100 nmol/L BFA.  Viable cell number was measured by MTT assay, and results were reported as a percentage relative to untreated 
cells.  (B) HepG2 cells were cultured for 72 h with the indicated concentrations of ATG in the presence of CHX (50 μmol/L), ADM (500 nmol/L) or BBR 
(10 μmol/L).  Cell growth rate was measured by MTT assay and results were reported as a percentage relative to untreated cells.  (C) HepG2 cells 
were cultured for 48 h in the presence or absence of ATG (5 μmol/L) and/or BFA (100 nmol/L) followed by staining with PI (15 μg/mL) for 15 min.   
Representative images of cellular morphology (top panel) and PI staining (bottom panel) were shown at 200×magnification.  (D) Cells were treated in 
the same way as in C.  PARP cleavage was examined by Western blot analysis.  Relative band intensity was normalized for GAPDH and expressed as a 
percentage compared with the value of untreated control.  n=3 experiments. Mean±SEM. 
bP<0.05, 
cP<0.01 vs control.945
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splicing form of XBP-1 mRNA (Figure 2A) as well as phospho-
rylation of eIF2α on serine (Ser) 51 (Figure 2B), which are two 
key events in the UPR.  And ATG significantly inhibited the 
BFA-induced splicing of XBP-1 pre-mRNA and phosphoryla-
tion of eIF2α (Figure 2A and 2B).  
We further used quantitative PCR to evaluate the effects 
of ATG on the expression of the downstream genes involved 
in the UPR, which include the activating transcription fac-
tor 4 (ATF4), the C/EBP homologous protein (CHOP), the 
glucose-regulated protein 94 (Grp94), and the ER degradation-
enhancing alpha-mannosidase-like protein 1 (EDEM).  Our 
data showed that ATG significantly inhibited BFA-induced 
expression of all four genes (Figure 2C).  In addition, we also 
investigated the effect of ATG on the UPR induced by tuni-
camycin (TM), another ER stress inducer that inhibits N-linked 
glycosylation in the ER.  As shown in supplymentary Figure 1, 
ATG significantly inhibited tunicamycin-induced splicing of 
XBP-1 pre-mRNA and mRNA expression of four downstream 
genes involved in the UPR.  These results demonstrate that 
ATG protects cells from BFA-induced apoptosis via alleviating 
ER stress, and suggest that ATG may act upstream of the UPR, 
since all downstream signaling pathways were affected.
ATG attenuates protein translation
In mammalian cells, global translation attenuation is the first 
response to ER stress and is thought to be an important adap-
tive response that helps cells survive ER stress.  Previous 
studies also reported that protein synthesis inhibitors such 
as cycloheximide
[19] and salubrinal
[20] displayed potential ER 
stress-relieving effects.  Therefore, inhibition of protein syn-
Figure 2.  ATG significantly inhibits ER stress-induced UPR.  (A) HepG2 cells were cultured for 6 h with or without ATG (5 μmol/L), in the presence or 
absence of BFA (100 nmol/L), and then lysed for RNA purification.  Spliced (S) and unspliced forms of XBP1 mRNA (U) were detected using semi-
quantitative RT-PCR.  (B) HepG2 cells were cultured with the indicated concentrations of ATG for 3 h in the presence or absence of BFA (100 nmol/L) 
followed by cell lysis.  The phosphorylation level of eIF2α at Ser51 was examined by Western blot analysis.  Total eIF2α served as a loading control.  The 
quantification of Western blot images of the ratio between P-eIF2α and eIF2α was shown in the lower panel.  (C) HepG2 cells were treated with 0, 2.5, 
or 5 μmol/L ATG for 6 h, in the presence or absence of BFA (100 nmol/L).  The expression levels of UPR downstream genes (Grp94, EDEM, ATF4 and 
CHOP) were examined by quantitative RT-PCR. n=3 experiments. Mean±SEM. 
cP<0.01 vs control.946
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thesis which reduces the load of substrates presented to the 
folding machinery in the ER lumen represents an important 
mechanism to alleviate ER stress
[21].  To explore whether ATG 
affects protein synthesis, we transfected HepG2 cells with a 
plasmid encoding green fluorescent protein (GFP), and evalu-
ated the effect of ATG on GFP expression by dividing the IOD 
(integral optical density) value of green fluorescence by the 
number of cells that was measured by Hoechst staining.  As 
shown in Figure 3A, 24 h after treatment with ATG, the level 
of GFP protein was decreased in a dose-dependent manner.   
Cycloheximide (CHX) served as a positive control.  However, 
neither artigenin nor CHX had effects on the mRNA level of 
GFP (Figure 3B).  These data indicate that ATG can inhibit 
protein synthesis, which in turn reduces the load on the ER 
and thereby relieves ER stress.  
To investigate how ATG regulates protein translation, we 
analyzed the effects of ATG on signaling proteins that are 
responsible for translational control, which include eIF2α, 
mTOR (the mammalian target of rapamycin) and p70S6K (p70 
ribosomal protein S6 kinase), two components in mTOR sig-
naling, and eEF2 (the eukaryotic translation elongation factor 
2).  Our data showed that ATG had no effects on the phos-
phorylation of eIF2α.  However, it significantly inhibited the 
phosphorylation of mTOR and p70S6K in a dose dependent 
manner, and increased the phosphorylation/inactivation of 
eEF2 at threonine (Thr) 56 (Figure 3C).  
We also examined the effects of ATG on these proteins in 
BFA-treated cells.  BFA induced an increase in eIF2α phospho-
rylation, which was inhibited by ATG (Figure 3D), although 
ATG alone had no effect on the basal level phosphorylation 
of eIF2α.  BFA had no effects on the phophorylation of either 
p70S6K or eEF2 (Figure 3D), suggesting that the inhibitory 
effect of ATG on protein translation was unaffected by BFA.
These data suggest that ATG attenuates protein synthesis 
likely through inhibiting mTOR-p70S6K signaling and eEF2 
activity.
ATG reduces the unfolded protein response by activating AMPK
It has been reported that AMPK acts upstream of mTOR sig-
naling and eEF2 in controlling translation.  AMPK modulates 
the activity of mTOR either by direct phosphorylation and 
inhibition of mTOR
[22], or by phosphorylation and activation 
of the tuberous sclerosis complex (TSC), an upstream regula-
tor and inhibitor of mTOR activity
[23].  The most characterized 
downstream effectors of mTOR are p70S6K and the eukaryotic 
translation initiation factor 4E (eIF4E)-binding protein 1 (4E-
BP1), through which mTOR stimulates the initiation step of 
translation
[24].  AMPK can also activate eEF2 kinase (eEF2K) 
either by direct phosphorylation of eEF2K at Ser398
[25], or by 
inhibition of p70S6K.  which phosphorylates and inactivates 
eEF2K at Ser366
[26].  Activated eEF2K in turn phosphorylates 
and inactivates eEF2 at Thr56
[27].  We therefore investigated 
the effect of ATG on AMPK phosphorylation/activation.  As 
shown in Figure 4, ATG significantly stimulated the phospho-
rylation of AMPK at Thr172 of α catalytic subunit in a time- 
and dose-dependent manner (Figure 4A and 4B).  ATG also 
increased the phosphorylation of ACC (acetyl-CoA carboxy-
lase) at Ser79, a direct substrate of AMPK
[28], indicating an 
increase in AMPK activity was induced (Figure 4B).
To determine whether the attenuation of protein translation 
by ATG is mediated by AMPK activation, we employed RNA 
interference to knock down AMPKα1.  As shown in Figure 4C, 
siRNA-mediated AMPKα1 down-regulation partially reversed 
the effect of ATG on the phosphorylation of p70S6K and eEF2.   
These data suggest that AMPK activation at least partially 
mediates the inhibitory effect of ATG on protein translation.
To further verify that the alleviation of ER stress by ATG is 
mediated by AMPK activation, we used a selective inhibitor of 
AMPK, compound C (CC), to block AMPK activity.  As shown 
in Figure 4D and 4E, compound CC significantly reduced the 
effects of ATG on the BFA-induced XBP-1 splicing and mRNA 
expression of Grp94, suggesting that the activation of AMPK 
is necessary for ATG’s inhibitory effect on the BFA-induced 
UPR.  Meanwhile, CC itself had no effects on the splicing of 
XBP-1 pre-mRNA (Figure 4D).  The involvement of AMPK 
in the ATG inhibition of ER stress was further confirmed by 
using a known AMPK activator AICAR.  Similar to artigenin, 
AICAR significantly prevented BFA-induced cell death in a 
dose-dependent manner (Figure 4F).
Taken together, our observations demonstrate that ATG 
alleviates ER stress probably through activating AMPK, which 
attenuates protein translation and reduces ER load.  
ATG inhibits mitochondrial respiration, leading to AMPK 
activation
There are two main protein kinases involved in phosphorylat-
ing AMPK in vivo, LKB1 (liver kinase B1) and Ca
2+/calmodu-
lin-denpendent protein kinase kinase, especially the β isoform 
(CaMKKβ)
[29].  To determine whether the two kinases are criti-
cally involved in the ATG-induced AMPK phosphorylation, 
we used RNA interference to down-regulate the expression 
of LKB1 and CaMKKβ.  As shown in Figure 5, knockdown of 
either LKB1 or CaMKKβ significantly reduced the phosphory-
lation of AMPK induced by ATG, suggesting that both kinases 
are involved in mediating the ATG-induced AMPK activation 
(Figure 5A).  
Phosphorylation of AMPK by the two kinases is regulated 
by adenosine monophosphate (AMP), which allosterically 
activates AMPK and makes it a better substrate for the two 
upstream kinases and a poorer substrate for protein phos-
phatases
[30].  The intracellular AMP level, however, is regu-
lated by adenosine triphosphate (ATP) content.  ATP depletion 
has been shown to increase AMP production as a consequence 
of the reaction catalyzed by adenylate kinase
[30].  To investigate 
whether ATG affects ATP production, we evaluated intracel-
lular ATP levels by a luciferase assay.  As shown in Figure 
5, intracellular ATP levels were reduced by ATG in a time-
dependent and dose-dependent manner (Figure 5B and 5C).
Given the fact that mitochondria are the major ATP produc-
tion organelles in eukaryotes, we investigated the effects of 
ATG on mitochondrial respiration in mitochondria isolated 
from rat muscle.  Our data showed that ATG inhibited oxygen 947
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Figure 3.  ATG moderately inhibits protein translation.  (A) HepG2 cells were transfected with a GFP-expressing plasmid for 16 h, and then treated for 
another 24 h with DMSO, CHX (5 μmol/L), or the indicated concentrations of ATG followed by staining with Hoechst 33342 (2 μg/mL) for 5 min.  At 
least six photographs per well in different areas of cell cultures were taken by fluorescence microscopy, and GFP expression was evaluated by dividing 
the IOD of green fluorescence by cell number.  The value of GFP expression treated with DMSO was considered as 100%.  (B) The expression levels 
of GFP mRNA were examined by quantitative RT-PCR.   (C) HepG2 cells were treated for the indicated times with different concentrations of ATG.  The 
phosphorylation levels of eIF2α, mTOR, p70S6K, and eEF2 were examined by Western blot analysis.  Relative band intensity was expressed as a 
percentage compared with the value of control at 0.25 h.  (D) HepG2 cells were cultured for 3 h in the presence or absence of ATG (5 μmol/L) and/
or BFA (100 nmol/L) followed by cell lysis.  The phosphorylation levels of eIF2α at Ser51, p70S6K at Thr389, and eEF2 at Thr56 were examined 
by Western blot analysis.  Relative band intensity was expressed as a percentage compared with the value of untreated control.  n=4 experiments. 
Mean±SEM. 
bP<0.05, 
cP<0.01 vs control.948
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Figure 4.  ATG activates AMPK and may lead to ER stress alleviation.  (A and B) HepG2 cells were incubated with 5 μmol/L ATG for the indicated time 
(A) or with ATG at the indicated concentrations for 1 h (B).  Phospho-AMPKα (Thr172), AMPKα1, and phospho-ACC (Ser79) were analyzed by Western 
blotting.  GAPDH served as a control.  Relative band intensity of each protein was expressed as a percentage compared with the value of untreated 
control.  (C) HepG2 cells were transfected with a negative control siRNA (NC) or a siRNA targeting AMPKα1.  At 48 h after transfection, cells were treated 
with or without ATG (5 μmol/L) for 1 h.  Phospho-AMPKα (Thr172), AMPKα1, phospho-p70S6K (Thr389, indicated by an arrowhead), p70S6K (indicated 
by an arrowhead), phospho-eEF2 (Thr56), eEF2, and GAPDH were examined by Western blot analysis.  The relative intensity of corresponding protein 
expression was shown in the right figures.  (D and E) Pretreated with DMSO or CC (25 μmol/L) for 1 h, HepG2 cells were exposed to ATG (5 μmol/L) 
and/or BFA (100 nmol/L) for 6 h.  Splicing of XBP1 mRNA was detected by semi-quantitative RT-PCR (D).  mRNA expression of Grp94 was detected 
by quantitative RT-PCR (E).  (F) HepG2 cells were treated with increasing concentrations of AICAR and 100 nmol/L BFA for 72 h.  Cell growth rate was 
evaluated by MTT assay.  n=4 experiments. Mean±SEM.  
bP<0.01, 
cP<0.01 vs control.949
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consumption in a dose-dependent manner in the presence of 
substrates for complex I (pyruvate plus malate).  In contrast, 
no effect of ATG on mitochondrial respiration was observed in 
the presence of substrate for complex II (succinate) and rote-
none (Figure 5D).
Taken together, our data demonstrate that ATG selectively 
inhibits mitochondrial respiration supported by substrates 
for complex I and decreases ATP production likely leading to 
AMPK phosphorylation/activation.
ATG protects INS-1 β-cells from palmitate-induced cell death
It has been reported that exposure to high concentrations of 
free (nonesterified) fatty acid (FFA) induces ER stress and 
causes β-cell apoptosis
[8, 31], which has been considered as one 
of the major causes of insufficient insulin production in type 2 
diabetes
[32, 33].  We therefore investigated the effects of ATG on 
palmitate-induced β-cell death.  Palmitate severely decreased 
cell viability of INS-1 β-cells, while treatment with ATG sig-
nificantly prevented cell death in a dose-dependent manner 
(Figure 6A).  We then investigated whether ATG could acti-
vate AMPK in INS-1 cells.  Our data showed that ATG signifi-
cantly increased the phosphorylation of AMPK in the absence 
or presence of palmitate (Figure 6B).  Furthermore, we exam-
ined the effects of ATG on palmitate-induced UPR in INS-1 
cells.  As shown in Figure 6C, 6D, and 6E, palmitate promoted 
the splicing of XBP-1 pre-mRNA and the mRNA expression 
of Grp78 and Grp94, which were significantly inhibited by 
ATG.  These data suggest that ATG protects INS-1 cells from 
palmitate-induced cell death probably through alleviating ER 
stress and the protective effects of ATG against ER stress are 
not specific in HepG2 cells.
Discussion
There has been growing interest in therapeutic strategies to 
alleviate ER stress, since prolonged ER stress has been associ-
ated with a wide range of pathological conditions
[5].  ER stress 
has been thought to play a central role in the pathogenesis of 
type 2 diabetes not only because of its role in the induction of 
insulin resistance but also because of its involvement in β-cell 
death, a common feature of type 2 diabetes
[34].  Therefore, com-
pounds that alleviate ER stress may act as therapeutic agents 
for the treatment of β-cell loss in type 2 diabetes.  In this study, 
we have identified ATG, a natural product from Arctium lappa 
L, as a candidate for alleviating ER stress.  
Firstly, we presented two lines of evidences to demonstrate 
that ATG was an ER stress alleviator (Figure 1, 2, and supple-
mentary Figure 1).  First, ATG protected HepG2 cells from ER 
stress inducer BFA-induced apoptosis, but showed no protec-
tive effect against non-ER stress stimuli.  Our data showed that 
the lowest effective dose of ATG is 2.5 µmol/L and ATG at 
Figure 5.  ATG inhibits mitochondrial respiration.  (A) HepG2 cells were transfected with a negative control siRNA (NC) or siRNA targeting LKB1 or 
CaMKKβ.  After 48 h of transfection, cells were treated with or without ATG (5 μmol/L) for 1 h.  Phospho-AMPKα (Thr172) and AMPKα1 were examined 
by Western blot analysis.  Relative band intensity was expressed as a percentage compared with the value of untreated control.  (B and C) Intracellular 
ATP levels were measured by the luciferin-luciferase method.  HepG2 cells were incubated with various concentrations of ATG for 1 h (B) or with 5 
μmol/L ATG for the indicated periods of time (C).  (D) Oxygen consumption rates were measured in mitochondria at 37°C using substrates combinations 
targeting respiratory complex I (5 mmol/L pyruvate plus 2 mmol/L malate) or complex II (10 mmol/L succinate plus 4 μmol/L rotenone). n=4 
experiments. Mean±SEM.  
bP<0.05, 
cP<0.01 vs control. 950
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higher dose (>10 µmol/L) displayed cytotoxicity, which might 
suggest a narrow therapeutic window.  However, our data 
also showed that the protective effect of ATG at 10 µmol/L 
was quite marked.  We therefore assume that ATG may have 
a wider therapeutic range in clinical settings.  Second, ATG 
inhibited BFA- and tunicamycin-induced UPR, ie, the splicing 
of XBP-1 pre-mRNA, the phosphorylation of eIF2α and the 
expression of downstream UPR target genes, including Grp94, 
EDEM, ATF4, and CHOP.  The UPR is involved in both sur-
vival and the apoptotic response
[35].  Whether a cell survives or 
dies upon ER stress will depend on the balance of these oppos-
ing signals.  In this case, BFA-induced ER stress caused cell 
apoptosis, which means that the pro-death signal overrides the 
pro-survival signal.  Inhibition of the UPR by ATG promoted 
cell survival, although ATG inhibited both pro-survival and 
pro-death signaling downstream of the UPR.  
To investigate whether ATG alleviates ER stress through 
attenuating protein synthesis, we analyzed the effects of ATG 
on the protein expression level of a transfected GFP gene.  Our 
data demonstrated that ATG decreased the level of GFP pro-
tein without influencing its transcription (Figure 3A and 3B).   
We also examined the effects of ATG on protein degradation 
and autophagy.  Our data showed that ATG had no effects on 
either protein degradation or autophagy (unpublished data).   
We therefore conclude that ATG reduced protein expression 
level by inhibiting protein translation but not transcription or 
degradation, by which ATG may relieve ER stress.
Unlike some of the ER stress alleviators, such as salubrinal 
which reduces ER load by inducing the phosphorylation of 
eIF2α
[20], therefore inhibiting the initiation of protein transla-
tion, ATG did not seem to affect the initiation factor eIF2α, 
but significantly inhibited phosphorylation of mTOR-p70S6K 
signaling and induced phosphorylation/inactivation of the 
protein translation elongation factor eEF2 (Figure 3C and 3D), 
suggesting that ATG attenuates protein synthesis by inhibiting 
both translation initiation and elongation.  
Therefore, inhibition of protein synthesis represents an effec-
tive strategy to reduce ER stress.  Once the protein synthesis is 
reduced, inhibition of downstream protein modification and/
or folding, as caused by BFA and/or TM, will no longer elicit 
an UPR.  Consistent with this notion, the BFA-induced phos-
phorylation of eIF2α is inhibited by ATG, although ATG itself 
does not directly affect eIF2α phosphorylation (Figure 3D).
Both mTOR-p70S6K signaling and eEF2 have been reported 
to be regulated by AMPK
[36].  We therefore investigated 
whether ATG activated AMPK, and if so, whether AMPK 
activation mediated ATG action.  Our data showed that ATG 
obviously increased the phosphorylation/activation of AMPK.   
Encouragingly, knockdown of AMPKα1 by RNA interference 
partially reversed the effect of ATG on the phosphorylation 
of p70S6K and eEF2.  Furthermore, an AMPK inhibitor, com-
pound C, could block the inhibitory effect of ATG on BFA-
induced XBP-1 splicing, whereas an AMPK activator, AICAR, 
could mimic ATG to reduce the ER stress-induced cell death.   
Figure 6.  ATG prevents palmitate-induced cell death and ER stress in INS-1 β-cells.  (A) INS-1 β-cells were incubated with the indicated concentrations 
of ATG in the presence of palmitate (2 mmol/L) for 24 h.  Cell growth rate was evaluated by MTT assay.  (B) INS-1 cells were treated with the indicated 
concentrations of ATG in the presence and absence of palmitate for 3 h.  Phospho-AMPKα (Thr172) and GAPDH were analyzed by Western blotting.  The 
quantification of Western blot images of the ratio between P-AMPKα and GAPDH was shown in the right panel.  (C, D, and E) INS-1 cells were incubated 
with the indicated concentrations of ATG and palmitate for 6 h, followed by RNA purification and reverse transcription.  Splicing of XBP1 mRNA in 
INS-1 β-cell was detected by semi-quantitative RT-PCR (C).  mRNA expressions of Grp78 (D) and Grp94 (E) were detected by quantitative RT-PCR.  n=4. 
Mean±SEM. 
bP<0.05, 
cP<0.01 vs control.951
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These data strongly suggest that AMPK plays a central role in 
mediating all of the ATG effects in alleviating ER stress.  Our 
results, together with an earlier report
[37], also indicate that 
activating AMPK could be an effective strategy for ER stress 
reduction.  
AMPK is widely recognized as a key regulator of fatty acid 
and glucose homeostasis
[30],
 and the activation of AMPK has 
been considered an attractive strategy for the treatment of 
type 2 diabetes.  The most representative compounds are met-
formin and berberine, which exert anti-diabetic effects through 
activating AMPK
[18, 38].  Meanwhile, they are also reported to 
possess protective effect against ER stress
[39–41].  Given the cru-
cial role of ER stress in the development of pancreatic β-cell 
loss and insulin resistance in type 2 diabetes
[6], the alleviation 
of ER stress by AMPK may play an important role in treating 
type 2 diabetes.  Consistent with this notion, our data demon-
strated that ATG also protected INS-1 β-cells against palmi-
tate-induced ER stress and cell death (Figure 6).  In addition, 
activating AMPK may also represent a potential therapeutic 
strategy to relieve ER stress in other ER stress-related diseases, 
since ER stress is associated with a number of diseases.
AMPK has been reported to be activated by its two main 
upstream kinases, LKB1 and CaMKKβ in response to 
decreased intracellular levels of ATP
[29].  Our data showed that 
AMPK phosphorylation induced by ATG was significantly 
inhibited by either LKB1 or CaMKKβ siRNAs, implying that 
both kinases are involved in ATG-induced AMPK phosphory-
lation (Figure 5A).  This is consistent with a recent study that 
reported ATG phosphorylated AMPK in H9C2 and C2C12 
cells via LKB1 and CaMKK-denpendent pathways
[42].  Further-
more, we found the intracellular ATP level was significantly 
reduced by ATG (Figure 5B and 5C), which might also lead 
to AMPK activation.  Interestingly, ATG at 0.5 μmol/L and 1 
μmol/L significantly increased AMPK phosphorylation but 
slightly reduced the intracellular ATP levels, which implies 
that ATG may also activate AMPK via an ATP depletion-
independent manner.  Taken together, our data suggest that 
ATG activates AMPK probably through activating LKB1 and 
CaMKKβ and/or decreasing the ATP level.
Since oxidative phosphorylation and glycolysis are the two 
main sources of ATP in eukaryotic cells, we then investigated 
the effects of ATG on mitochondrial respiratory function.  Our 
data demonstrated that ATG inhibited oxygen consumption 
supported by substrates for complex I but not that supported 
by complex II substrates (Figure 5D), indicating that the inhi-
bition of mitochondrial respiration by ATG was occurring 
either at the level of NADH production or at complex I.  These 
results suggest that ATG decreases the intracellular level of 
ATP and increases the phosphorylation/activity of AMPK 
through inhibiting mitochondrial respiration.
In conclusion, our findings reveal the molecular mechanism 
by which ATG alleviates ER stress: the inhibition of mitochon-
drial respiration by ATG results in reduced ATP production in 
mitochondria.  Under conditions of energy depletion, AMPK 
is probably activated by LKB1 and CaMKKβ, which in turn 
inhibits mTOR-p70S6K signaling and increases eEF2 phos-
phorylation/inactivation, leading to the attenuation of protein 
synthesis.  As a result, the burden of ER stress is relieved, and 
cell death is prevented (Figure 7).  We also show the protective 
effect of ATG against palmitate-induced INS-1 β-cell death.   
These data suggest that ATG may represent a potential thera-
peutic intervention for treating ER stress-related diseases, such 
as β-cell loss in type 2 diabetes.  
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